YU321279A - Process for obtaining substituted 3,4-dimethoxy-beta-phenetylamines - Google Patents

Process for obtaining substituted 3,4-dimethoxy-beta-phenetylamines

Info

Publication number
YU321279A
YU321279A YU03212/79A YU321279A YU321279A YU 321279 A YU321279 A YU 321279A YU 03212/79 A YU03212/79 A YU 03212/79A YU 321279 A YU321279 A YU 321279A YU 321279 A YU321279 A YU 321279A
Authority
YU
Yugoslavia
Prior art keywords
phenetylamines
dimethoxy
beta
obtaining substituted
substituted
Prior art date
Application number
YU03212/79A
Other versions
YU37113B (en
Inventor
Ralph Tuttle Ronald
Tuttle Ronald Ralph
Mills Jack
Jack Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU321279(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU321279A publication Critical patent/YU321279A/en
Publication of YU37113B publication Critical patent/YU37113B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU3212/79A 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine YU37113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
YU321279A true YU321279A (en) 1983-04-27
YU37113B YU37113B (en) 1984-08-31

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines
YU3212/79A YU37113B (en) 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)
KR (1) KR790000113B1 (en)
AR (1) AR203822A1 (en)
AT (1) AT323719B (en)
AU (1) AU472734B2 (en)
BE (1) BE798051A (en)
BG (1) BG23001A3 (en)
CA (1) CA1018188A (en)
CH (2) CH569691A5 (en)
CS (2) CS190448B2 (en)
CY (1) CY963A (en)
DD (1) DD107670B3 (en)
DE (1) DE2317710C2 (en)
DK (1) DK142750C (en)
ES (1) ES413639A1 (en)
FR (1) FR2182947B1 (en)
GB (1) GB1392674A (en)
HK (1) HK50178A (en)
HU (2) HU166213B (en)
IE (1) IE37511B1 (en)
IL (1) IL42016A (en)
KE (1) KE2870A (en)
MY (1) MY7800381A (en)
NL (1) NL174459C (en)
PH (1) PH11041A (en)
PL (2) PL94207B1 (en)
RO (2) RO65105A (en)
SE (1) SE399064B (en)
SU (1) SU496719A3 (en)
YU (2) YU36483B (en)
ZA (1) ZA732136B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ES8702355A1 (en) * 1981-07-22 1985-07-01 Syntex Inc Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use.
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (en) * 1989-12-18 1991-08-23
WO1992020645A1 (en) * 1991-05-20 1992-11-26 Tsumura & Co. Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
ATE155125T1 (en) * 1993-04-13 1997-07-15 Duphar Int Res PRODUCTION OF DOBUTAMIN COMPOUNDS
CA2500935C (en) 2002-10-03 2014-09-23 New Era Biotech, Ltd. Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
EP1750691B1 (en) 2004-03-26 2016-08-10 Novaremed Ltd. Compounds for treatment of aids and other diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
EP2458983B1 (en) 2009-07-31 2015-07-08 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
US20170197977A9 (en) * 2011-08-25 2017-07-13 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
ES2721001T3 (en) 2014-01-31 2019-07-26 Cognition Therapeutics Inc Isoindoline derivative, and compositions and methods to treat a neurodegenerative disease
US11214540B2 (en) 2017-05-15 2022-01-04 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
CN114524734B (en) * 2021-12-27 2024-04-26 嘉实(湖南)医药科技有限公司 Preparation method of dobutamine hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
AT323719B (en) 1975-07-25
IE37511B1 (en) 1977-08-03
KE2870A (en) 1978-09-01
CH569691A5 (en) 1975-11-28
ZA732136B (en) 1974-03-27
DK142750C (en) 1981-08-17
AU472734B2 (en) 1976-06-03
YU37113B (en) 1984-08-31
GB1392674A (en) 1975-04-30
DK142750B (en) 1981-01-12
IL42016A (en) 1976-05-31
CS190406B2 (en) 1979-05-31
NL174459B (en) 1984-01-16
YU36483B (en) 1984-02-29
DD107670A5 (en) 1974-08-12
JPS58131945A (en) 1983-08-06
DD107670B3 (en) 1988-04-06
PL90695B1 (en) 1977-01-31
DE2317710A1 (en) 1973-10-18
ES413639A1 (en) 1976-01-16
RO65105A (en) 1980-01-15
RO70892A (en) 1982-02-26
IL42016A0 (en) 1973-06-29
HK50178A (en) 1978-09-15
AU5438573A (en) 1974-10-17
YU97673A (en) 1982-02-25
CH580563A5 (en) 1976-10-15
FR2182947A1 (en) 1973-12-14
PH11041A (en) 1977-10-25
NL174459C (en) 1984-06-18
DE2317710C2 (en) 1983-08-04
HU167597B (en) 1975-11-28
CA1018188A (en) 1977-09-27
BG23001A3 (en) 1977-05-20
HU166213B (en) 1975-02-28
JPS5825656B2 (en) 1983-05-28
MY7800381A (en) 1978-12-31
SE399064B (en) 1978-01-30
SU496719A3 (en) 1975-12-25
NL7305097A (en) 1973-10-16
PL94207B1 (en) 1977-07-30
CS190448B2 (en) 1979-05-31
AR203822A1 (en) 1975-10-31
KR790000113B1 (en) 1979-03-20
BE798051A (en) 1973-10-11
CY963A (en) 1978-12-22
FR2182947B1 (en) 1976-07-02
JPS6221343B2 (en) 1987-05-12
JPS497237A (en) 1974-01-22

Similar Documents

Publication Publication Date Title
YU254979A (en) Process for preparing new 3,4-dihydrocarbostyryl-derivatives
YU37113B (en) Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine
YU39715B (en) Process for obtaining substituted omega-pentanoprostaglandins
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
YU39297B (en) Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones
YU310573A (en) Process for obtaining 3-hydroxycephalosporins
YU133872A (en) Process for obtaining diphenyl-alkanoylamino-pyridines
YU35452B (en) Process for obtaining d-homosteroids
YU40095B (en) Process for obtaining 1,2-dialkyl-3,5-diphenylpirazolium salts
YU36149B (en) Process for obtaining isopropylamines
YU269273A (en) Process for obtaining 2,10-dichloro-12-methyl-12h-dibenzo (d.g.)-(1,3)dioxocines
YU200474A (en) Process for obtaining novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
YU35149B (en) Process for obtaining 15 delta, 16-methylene-4-pregnene
YU229979A (en) Process for obtaining novel 1,4-benzodixane derivatives
YU318473A (en) Process for obtaining m-dioxane-5-methylamines
YU146973A (en) Process for obtaining oxo-prostaglandins
YU49973A (en) Process for obtaining n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine
YU36701B (en) Process for obtaining as-triazinoz5,6-ccquinoline derivatives
YU36972B (en) Process for obtaining 7-acylamido-7-alkoxycephalosporins
YU240180A (en) Process for obtaining deacetoxy-cephalosporin
YU35273B (en) Process for obtaining bicyclomycine
CS191448B1 (en) Process for preparing 6,7-dihydrobenztrazole
YU45373A (en) Process for preparing 6,9-dioxo-8-hydroxy-2-(3,4-dihydroxyphenyl)-bicyclo-(3,3,1)-7-nomene-3-01
YU34896B (en) Process for preparing substituted 2-aryla inoimidazolines-(2)
YU39001B (en) Process for preparing new 3,4-dihydrocarbostyryl derivatives